We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Eli Lilly Sues Actavis To Block Generic ADHD Drug

Law360 (August 10, 2007, 12:00 AM EDT) -- Eli Lilly & Co. has filed a lawsuit against a U.S. subsidiary of Iceland-based Actavis, looking to stave off generic competition in the $509 million annual U.S. market for the attention-deficit...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.